<SEC-DOCUMENT>0001144204-15-051200.txt : 20150821
<SEC-HEADER>0001144204-15-051200.hdr.sgml : 20150821
<ACCEPTANCE-DATETIME>20150821101730
ACCESSION NUMBER:		0001144204-15-051200
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150821
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150821
DATE AS OF CHANGE:		20150821

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11504
		FILM NUMBER:		151067883

	BUSINESS ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205
		BUSINESS PHONE:		410-369-0365

	MAIL ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS BIOTECHNOLOGY, INC.
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v418844_8k.htm
<DESCRIPTION>8-K CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 34%; text-align: justify; font-weight: bold; border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: justify; font-weight: bold; border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: justify; font-weight: bold; border-bottom: Black 2.5pt double">&nbsp;</TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>_________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT PURSUANT TO SECTION 13
OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
<B>August 21, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CHAMPIONS ONCOLOGY, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; text-align: justify; font-weight: bold">Delaware</TD>
    <TD STYLE="width: 34%; text-align: center; font-weight: bold">0-17263</TD>
    <TD STYLE="width: 33%; text-align: center; font-weight: bold">52-1401755&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(IRS Employer</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">of Incorporation)</FONT></TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: center">Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1 University Plaza, Suite 307, Hackensack,
New Jersey 07601</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Registrant&rsquo;s telephone number, including
area code: <B>(410) 369-0365</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="width: 97%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION TO BE INCLUDED IN THE REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: justify"><B>Item 8.01. </B></TD>
    <TD STYLE="width: 90%; text-align: justify"><B>Other Events. </B></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9.35pt">On August 21, 2015,&nbsp;Champions Oncology,
Inc. (the &ldquo;Company&rdquo;) issued a press release announcing that its common stock has been approved for listing on The NASDAQ
Capital Market.&nbsp; The Company expects its common stock to begin trading at the opening of trading on August 21, 2015 under
the trading symbol &ldquo;CSBR.&rdquo;&nbsp; A copy of the press release is attached hereto as Exhibit&nbsp;99.1 and is incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><B>Item 9.01.</B></TD>
    <TD STYLE="width: 90%"><B>Financial Statements and Exhibits.</B></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following exhibit filed herewith:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Exhibit No.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release dated August 21, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>_____________________________________________________________________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt"><B></B></FONT></TD>
    <TD STYLE="width: 45%"><B>CHAMPIONS ONCOLOGY, INC.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"></FONT></TD>
    <TD>(Registrant)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date: August 21, 2015</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Joel Ackerman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-size: 10pt">Joel Ackerman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v418844_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 83%; font-size: 10pt"><img src="image_001.jpg" alt="" style="height: 84px; width: 251px"></td>
    <TD STYLE="width: 17%; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #0070C0; text-align: left"><FONT STYLE="font-size: 8pt">One
        University Plaza</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #0070C0; text-align: left"><FONT STYLE="font-size: 8pt">Suite
        307</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #0070C0; text-align: left"><FONT STYLE="font-size: 8pt">Hackensack,
        NJ 07601</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #0070C0; text-align: left"><FONT STYLE="font-size: 8pt">Phone:
        201-808-8400</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-size: 8pt; color: Blue"><U>www.championsoncology.com</U></FONT></P></td></tr>
</table>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Champions Oncology Announces Uplisting
to NASDAQ</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hackensack, NJ &ndash; August 21, 2015 &ndash; Champions Oncology,
Inc. (CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of
oncology drugs, announced that it has commenced trading on the NASDAQ Capital Market effective today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Joel Ackerman, Chief Executive Officer commented, &ldquo;Uplisting
to a national exchange like NASDAQ has been a goal towards which we have been working for years. We are pleased to reach this important
milestone in the Company&rsquo;s history. We expect this will provide us with increased visibility in the capital markets and access
to a broader investor base, which ultimately should provide us with better access to capital.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Champions&rsquo; common stock began trading under the same symbol
(CSBR) at the opening of trading on August 21, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">About Champions Oncology, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Champions Oncology, Inc. is engaged in the development of advanced
technology solutions and services to personalize the development and use of oncology drugs. The Champions TumorGraft&reg; technology
platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune deficient
mice followed by propagation of the resulting engraftments in a manner that preserves the biological characteristics of the original
human tumor in order to determine the efficacy of a treatment regimen. The Company uses this technology in conjunction with related
services to offer solutions for two customer groups: Personalized Oncology Solutions, in which results help guide the development
of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical and biotechnology companies seeking
personalized approaches to drug development can lower the cost and increase the speed of developing new drugs. Champions TumorGraft
models are procured through agreements with a number of institutions in the U.S. and overseas as well as through Champions&rsquo;
Personalized Oncology Solutions business. For more information, please visit www.championsoncology.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Forward Looking Statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release may contain &quot;forward-looking statements&quot;
(within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties. Champions
Oncology generally uses words such as &quot;believe,&quot; &quot;may,&quot; &quot;could,&quot; &quot;will,&quot; &quot;intend,&quot;
&quot;expect,&quot; &quot;anticipate,&quot; &quot;plan,&quot; and similar expressions to identify forward-looking statements.
One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially
from those anticipated in the forward-looking statements for many unforeseen factors. See Champions Oncology's Form 10-K for the
fiscal year ended April 30, 2015 for a discussion of such risks, uncertainties and other factors. Although the Company believes
the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which
the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet
these expectations. The Company does not intend to update any of the forward-looking statements after the date of this press release
to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; color: #0070C0"><I>Creating Greater Certainty in the Fight Against Cancer</I></P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !4 /L# 2(  A$! Q$!_\0
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MC[.UBL;2*V@!$<2A5!.3CZU-117F-W=V>XDDK(****0PHHHH **** "BBB@
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MKC:BXP<'/-,\2WSP:,SVLVS=(D<DJ')C4GDU1,,6D:SIJ:9=RR_:7*S1-,9
MR8SO]L>M"K.G+W?ZN:57&7NR5UH;]_86^IVCVUW&)(GZ@]CZ@]C7,'X<V?F'
M%]="$G/E\?S_ /K4VXQ?RZI/=O<23VTYC2WCN/*\J,=&'8^M7+ZYD&C66O69
M=6@C!>*1R?,C/!!]3WS3IXR=-/E=D8U(4JSYIQO;\C;T[3;;2K1;:SC"1CD]
MRQ]2>YJG:>'H;/7KG55FD:6<$%#C:,X_PJ;1+.2UL UQ*TMS.?-E8G(R>P]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
